The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Open accessAbstract
BACKGROUND: Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS: In a multicenter, double-blind, randomized trial, we assigned 970 patients with an acute anterior ST-segment elevation myocardial infarction (STEMI) who were undergoing percutaneous coronary intervention (PCI) within 12 hours after symptom onset and who had complete occlusion of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenously at a dose of 2.5 mg per kilogram of body weight) or matching placebo before coronary recanalization. The primary outcome was a composite of death from any cause, worsening of heart failure during the initial hospitalization, rehospitalization for heart failure, or adverse left ventricular remodeling at 1 year. Adverse left ventricular remodeling was defined as an increase of 15% or more in the left ventricular end-diastolic volume. RESULTS: A total of 395 patients in the cyclosporine group and 396 in the placebo group received the assigned study drug and had data that could be evaluated for the primary outcome at 1 year. The rate of the primary outcome was 59.0% in the cyclosporine group and 58.1% in the control group (odds ratio, 1.04; 95% confidence interval [CI], 0.78 to 1.39; P=0.77). Cyclosporine did not reduce the incidence of the separate clinical components of the primary outcome or other events, including recurrent infarction, unstable angina, and stroke. No significant difference in the safety profile was observed between the two treatment groups. CONCLUSIONS: In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with relatively deceiving results (despite multiple clinical trials, no drug based on this concept has ever been approved for use in humans by regulatory agencies) [387].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [387]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Mario, C. D., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,890
Self-citationYellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Self-citationEvolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & de Werf, F. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,014
Self-citationMitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion
Griffiths, E. J., & Halestrap, A. P. (1995) · Biochemical Journal · doi:10.1042/bj3070093 · Cited by 838
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
Jolly, S. S., Cairns, J. A., Yusuf, S., Meeks, B., Pogue, J. M., Rokoss, M. J., Kedev, S. A., Thabane, L., Stankovic, G. R., Moreno, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415098 · Cited by 665
Self-citationSteg, P. G., Greenlaw, N., Tardif, J., Tendera, M., Ford, I., Kääb, S., Abergel, H., Fox, K. M., Ferrari, R., & on behalf of the CLARIFY Registry Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs289 · Cited by 653
Self-citationHausenloy, D. J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00455-8 · Cited by 585
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,271
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Re, D. P. D., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 994
Mitochondrial dysfunction and oxidative stress in heart disease
Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0355-7 · Cited by 950
The machineries, regulation and cellular functions of mitochondrial calcium
Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941
Ong, S., Hernández‐Reséndiz, S., Crespo-Avilan, G. E., Талгатовна, М. Р., Kwek, X.-Y., Cabrera-Fuentes, H. A., & Hausenloy, D. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.001 · Cited by 952
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 846
Spatial multi-omic map of human myocardial infarction
Kuppe, C., Ramirez Flores, R. O., Li, Z., Hayat, S., Levinson, R. T., Liao, X., Hannani, M. T., Tanevski, J., Wünnemann, F., Nagai, J. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05060-x · Cited by 772
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
Davidson, S. M., Ferdinandy, P., Andreadou, I., Bøtker, H. E., Heusch, G., Ibáñez, B., Ovize, M., Schulz, R., Yellon, D. M., Hausenloy, D. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.086 · Cited by 710
Self-citationHeusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 679
Ischaemic conditioning and reperfusion injury
Hausenloy, D. J., & Yellon, D. M. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.5 · Cited by 584
Mitochondrial ROS in myocardial ischemia reperfusion and remodeling
Bugger, H., & Pfeil, K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165768 · Cited by 480
Mitochondrial Function, Biology, and Role in Disease
Murphy, E., Ardehali, H., Balaban, R. S., Lisa, F. D., Dorn, G. W., Kitsis, R. N., Otsu, K., Ping, P., Rizzuto, R., Sack, M. N., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000104 · Cited by 476
Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death
Bauer, T. M., & Murphy, E. (2020) · Circulation Research · doi:10.1161/circresaha.119.316306 · Cited by 450
Inflammation in acute myocardial infarction: the good, the bad and the ugly
Matter, M. A., Paneni, F., Libby, P., Frantz, S., Stähli, B. E., Templin, C., Mengozzi, A., Wang, Y.-J., Kündig, T. M., Räber, L., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad486 · Cited by 404
Zhu, P., Hu, S., Jin, Q., Li, D., Tian, F., Toan, S., Li, Y., Zhou, H., & Chen, Y. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.019 · Cited by 379
Hausenloy, D. J., García‐Dorado, D., Bøtker, H. E., Davidson, S. M., Downey, J. M., Engel, F. B., Jennings, R. B., Lecour, S., Leor, J., Madonna, R., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx049 · Cited by 356
Self-citationMitochondria in acute myocardial infarction and cardioprotection
Ramachandra, C. J. A., Hernández‐Reséndiz, S., Crespo-Avilan, G. E., Lin, Y., & Hausenloy, D. J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102884 · Cited by 348
Hausenloy, D. J., Bøtker, H. E., Engstrøm, T., Erlinge, D., Heusch, G., Ibáñez, B., Kloner, R. A., Ovize, M., Yellon, D. M., & García‐Dorado, D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw145 · Cited by 326
Self-citationLi, Y., Chen, B., Yang, X., Zhang, C., Yao, J., Li, P., Liu, Y., Li, Z., Qiao, B., Lau, W. B., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.039262 · Cited by 317
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
Hausenloy, D. J., Barrabés, J. A., Bøtker, H. E., Davidson, S. M., Lisa, F. D., Downey, J. M., Engstrøm, T., Ferdinandy, P., Carbrera-Fuentes, H. A., Heusch, G., et al. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0588-8 · Cited by 309
Self-citationAbbate, A., Trankle, C. R., Buckley, L. F., Lipinski, M. J., Appleton, D. L., Kadariya, D., Canada, J. M., Carbone, S., Roberts, C. S., Abouzaki, N. A., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014941 · Cited by 309
Critical Issues for the Translation of Cardioprotection
Heusch, G. (2017) · Circulation Research · doi:10.1161/circresaha.117.310820 · Cited by 299
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 308
Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges
Huang, S., & Frangogiannis, N. G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14155 · Cited by 283
Kapur, N. K., Alkhouli, M. A., DeMartini, T. J., Faraz, H. A., George, Z. H., Goodwin, M. J., Hernández-Montfort, J., Iyer, V., Josephy, N., Kalra, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038269 · Cited by 278
Konijnenberg, L. S. F., Damman, P., Duncker, D. J., Kloner, R. A., Nijveldt, R., van Geuns, R., Berry, C., Riksen, N. P., Escaned, J., & van Royen, N. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz301 · Cited by 267
Hausenloy, D. J., Chilian, W. M., Crea, F., Davidson, S. M., Ferdinandy, P., García‐Dorado, D., van Royen, N., Schulz, R., & Heusch, G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy286 · Cited by 271
Management of No-Reflow Phenomenon in the Catheterization Laboratory
Rezkalla, S. H., Stankowski, R. V., Hanna, J. M., & Kloner, R. A. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.11.059 · Cited by 263
The Coronary Circulation as a Target of Cardioprotection
Heusch, G. (2016) · Circulation Research · doi:10.1161/circresaha.116.308640 · Cited by 233
Zhang, C.-X., Cheng, Y., Liu, D., Liu, M., Cui, H., Zhang, B., Mei, Q., & Zhou, S. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0451-9 · Cited by 233
Reducing myocardial infarct size: challenges and future opportunities
Bulluck, H., Yellon, D. M., & Hausenloy, D. J. (2015) · Heart · doi:10.1136/heartjnl-2015-307855 · Cited by 232
Optimized Treatment of ST-Elevation Myocardial Infarction
Niccoli, G., Montone, R. A., Ibáñez, B., Thiele, H., Crea, F., Heusch, G., Bulluck, H., Hausenloy, D. J., Berry, C., Stiermaier, T., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315344 · Cited by 227
Adverse Remodeling and Reverse Remodeling After Myocardial Infarction
Bhatt, A. S., Ambrosy, A. P., & Velazquez, E. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0876-4 · Cited by 224
Davidson, S. M., Adameová, A., Barile, L., Cabrera-Fuentes, H. A., Lazou, A., Pagliaro, P., Stensløkken, K., García‐Dorado, D., & (CA16225), T. E. C. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15127 · Cited by 209
Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties
Izzo, V., Bravo-San Pedro, J. M., Sica, V., Kroemer, G., & Galluzzi, L. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.04.006 · Cited by 205
Cyclosporine A in Reperfused Myocardial Infarction
Ottani, F., Latini, R., Staszewsky, L. I., Vecchia, L. L., Locuratolo, N., Sicuro, M., Masson, S., Barlera, S., Milani, V., Lombardi, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.081 · Cited by 202
Time to Give Up on Cardioprotection?
Heusch, G., & Rassaf, T. (2016) · Circulation Research · doi:10.1161/circresaha.116.308736 · Cited by 200
Mitochondrial permeability transition pore-dependent necrosis
Robichaux, D. J., Harata, M., Murphy, E., & Karch, J. M. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.11.003 · Cited by 197
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction
Buono, M. G. D., Moroni, F., Montone, R. A., Azzalini, L., Sanna, T., & Abbate, A. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01766-6 · Cited by 187
Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets
Briston, T., Selwood, D. L., Szabadkai, G., & Duchen, M. R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.11.004 · Cited by 190
Updates on Acute Coronary Syndrome
Eisen, A., Giugliano, R. P., & Braunwald, E. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2049 · Cited by 182
Audia, J. P., Yang, X., Crockett, E. S., Housley, N. A., Haq, E. U., O’Donnell, K., Cohen, M. V., Downey, J. M., & Alvarez, D. F. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0692-z · Cited by 179
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction
Galli, M., Niccoli, G., Maria, G. L. D., Brugaletta, S., Montone, R. A., Vergallo, R., Benenati, S., Magnani, G., D’Amario, D., Porto, I., et al. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00953-4 · Cited by 177
Targeting Myocardial Reperfusion Injury — The Search Continues
Hausenloy, D. J., & Yellon, D. M. (2015) · New England Journal of Medicine · doi:10.1056/nejme1509718 · Cited by 172
Yu, L., Huang, B. S., Po, S. S., Tan, T., Wang, M., Zhou, L., Meng, G., Yuan, S., Zhou, X., Li, X., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.04.036 · Cited by 164
Wei, Z., Chen, Z., Zhao, Y., Fan, F., Xiong, W., Song, S., Yin, Y., Hu, J., Yang, K., Yang, L., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121000 · Cited by 163
Ferdinandy, P., Andreadou, I., Baxter, G. F., Bøtker, H. E., Davidson, S. M., Dobrev, D., Gersh, B. J., Heusch, G., Lecour, S., Ruiz‐Meana, M., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000348 · Cited by 170
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
Nakayama, H., & Otsu, K. (2018) · Biochemical Journal · doi:10.1042/bcj20170714 · Cited by 160
Francisco, J. J., & Re, D. P. D. (2023) · Antioxidants · doi:10.3390/antiox12111944 · Cited by 165
The mitochondrial permeability transition pore: an evolving concept critical for cell life and death
Morciano, G., Naumova, N., Koprowski, P., Valente, S. A., Sardão, V. A., Potes, Y., Rimessi, A., Wieckowski, M. R., & Oliveira, P. J. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12764 · Cited by 161
Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials
Nguyen, B. Y., Ruiz‐Velasco, A., Bùi, T. A., Collins, L., Wang, X., & Liu, W. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14431 · Cited by 156
Succinate metabolism: a new therapeutic target for myocardial reperfusion injury
Pell, V. R., Chouchani, E. T., Frezza, C., Murphy, M. P., & Krieg, T. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw100 · Cited by 149
Pasupathy, S., Tavella, R., Grover, S., Raman, B., Procter, N. E. K., Du, Y., Mahadavan, G., Stafford, I., Heresztyn, T., Holmes, A. S., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027575 · Cited by 146
Mitochondrial dysfunction and mitochondrial therapies in heart failure
Wu, C., Zhang, Z., Zhang, W., & Liu, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106038 · Cited by 148
Miyamoto, H. D., Ikeda, M., Ide, T., Tadokoro, T., Furusawa, S., Abe, K., Ishimaru, K., Enzan, N., Sada, M., Yamamoto, T., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.03.012 · Cited by 143
Nonapoptotic cell death in acute kidney injury and transplantation
Linkermann, A. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.008 · Cited by 141
Heusch, G., Andreadou, I., Bell, R., Bertero, E., Bøtker, H. E., Davidson, S. M., Downey, J. M., Eaton, P., Ferdinandy, P., Gersh, B. J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102894 · Cited by 141
Novel targets for mitochondrial medicine
Wang, W., Karamanlidis, G., & Tian, R. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7410 · Cited by 142
Fujisue, K., Sugamura, K., Kurokawa, H., Matsubara, J., Ishii, M., Izumiya, Y., Kaikita, K., & Sugiyama, S. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0949 · Cited by 137
Physiopathology of the Permeability Transition Pore: Molecular Mechanisms in Human Pathology
Bonora, M., Patergnani, S., Ramaccini, D., Morciano, G., Pedriali, G., Kahsay, A., Bouhamida, E., Giorgi, C., Wieckowski, M., & Pinton, P. (2020) · Biomolecules · doi:10.3390/biom10070998 · Cited by 135
Unlocking the Secrets of Mitochondria in the Cardiovascular System
Tian, R., Colucci, W. S., Arany, Z. P., Bachschmid, M. M., Ballinger, S. W., Boudina, S., Bruce, J. E., Busija, D. W., Dikalov, S., Dorn, G. W., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040551 · Cited by 135
Akodad, M., Lattuca, B., Nagot, N., Georgescu, V., Buisson, M., Cristol, J., Leclercq, F., Macia, J., Gervasoni, R., Cung, T.-T., et al. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.10.004 · Cited by 130
Self-citationMechanistic Role of mPTP in Ischemia-Reperfusion Injury
Morciano, G., Bonora, M., Campo, G. C., Aquila, G., Rizzo, P., Giorgi, C., Wieckowski, M. R., & Pinton, P. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_9 · Cited by 132
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments
Montecucco, F., Carbone, F., & Schindler, T. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv592 · Cited by 128
The mitochondrial permeability transition pore in AD 2016: An update
Biasutto, L., Azzolini, M., Szabó, I., & Zoratti, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.012 · Cited by 131
Inflammatory Mediators of Endothelial Dysfunction
Dri, E., Lampas, E., Lazaros, G. A., Lazarou, E., Theofilis, P., Tsioufis, C. P., & Tousoulis, D. (2023) · Life · doi:10.3390/life13061420 · Cited by 132
Programmed necrosis in heart disease: Molecular mechanisms and clinical implications
Zhu, H., & Sun, A. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.018 · Cited by 127
Kleinbongard, P., Bøtker, H. E., Ovize, M., Hausenloy, D. J., & Heusch, G. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14839 · Cited by 132
Self-citationNakano, Y., Matoba, T., Tokutome, M., Funamoto, D., Katsuki, S., Ikeda, G., Nagaoka, K., Ishikita, A., Nakano, K., Koga, J., et al. (2016) · Scientific Reports · doi:10.1038/srep29601 · Cited by 126
The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies
Muntean, D. M., Sturza, A., Dănilă, M. D., Borza, C., Duicu, O., & Mornoş, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8254942 · Cited by 124
Ikeda, G., Matoba, T., Nakano, Y., Nagaoka, K., Ishikita, A., Nakano, K., Funamoto, D., Sunagawa, K., & Egashira, K. (2016) · Scientific Reports · doi:10.1038/srep20467 · Cited by 121
Mitochondrial calcium and reactive oxygen species in cardiovascular disease
Murphy, E., & Liu, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac134 · Cited by 123
Auffret, V., Cottin, Y., Leurent, G., Gilard, M., Beer, J., Zabalawi, A., Chague, F., Filippi‐Codaccioni, E., Brunet, D., Hacot, J. P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy127 · Cited by 119
Self-citationMitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 123
Manolis, A. S., Manolis, A. A., Manolis, T. A., Apostolaki, N. E., Apostolopoulos, E. J., Melita, H., & Katsiki, N. (2020) · Medicinal Research Reviews · doi:10.1002/med.21732 · Cited by 116
Abbate, A., Wohlford, G. F., Buono, M. G. D., Chiabrando, J. G., Markley, R., Turlington, J., Kadariya, D., Trankle, C. R., Biondi‐Zoccai, G., Lipinski, M. J., et al. (2021) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvab075 · Cited by 115
Cyclophilin D, Somehow a Master Regulator of Mitochondrial Function
Porter, G. A., & Beutner, G. (2018) · Biomolecules · doi:10.3390/biom8040176 · Cited by 117
Xing, Y., Sui, Z., Liu, Y., Wang, M., Wei, X., Lu, Q., Wang, X., Liu, N., Chen, L., Chen, R., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00930-x · Cited by 113
Heusch, G. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00139.2019 · Cited by 110
The in vivo evidence for regulated necrosis
Tonnus, W., & Linkermann, A. (2017) · Immunological Reviews · doi:10.1111/imr.12551 · Cited by 114
Cellular recruitment in myocardial ischaemia/reperfusion injury
Bonaventura, A., Montecucco, F., & Dallegri, F. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12633 · Cited by 111
Crosstalk between macrophages and cardiac cells after myocardial infarction
Jian, Y., Zhou, X. J., Shan, W., Chen, C., Ge, W., Cui, J., Yi, W., & Sun, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01105-4 · Cited by 114
Ishikita, A., Matoba, T., Ikeda, G., Koga, J., Mao, Y., Nakano, K., Takeuchi, O., Sadoshima, J., & Egashira, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003872 · Cited by 108
Rao, S. V., Zeymer, U., Douglas, P. S., Al‐Khalidi, H. R., White, J. A., Liu, J., Levy, H. A., Guetta, V., Gibson, C. M., Tanguay, J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.053 · Cited by 106
Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMI
Rodríguez-Palomares, J. F., Gavara, J., González, I. F., Valente, F. X., Ríos‐Navarro, C., Rodríguez‐García, J., Bonanad, C., del Blanco, B. G., Miñana, G., Mutuberría, M., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.02.025 · Cited by 105
Jang, S., Lewis, T. S., Powers, C., Khuchua, Z., Baines, C. P., Wipf, P., & Javadov, S. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6635 · Cited by 103
Cyclophilin D: An Integrator of Mitochondrial Function
Amanakis, G., & Murphy, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00595 · Cited by 104
Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
Prag, H. A., Aksentijević, D., Dannhorn, A., Giles, A. V., Mulvey, J. F., Sauchanka, O., Du, L., Bates, G. R., Reinhold, J., Kula‐Alwar, D., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320717 · Cited by 103
Yang, K., Gao, R., Chen, H., Hu, J., Zhang, P., Wei, X., Shi, J., Chen, Y., Zhang, L., Chen, J., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae205 · Cited by 103
Liu, T., Howarth, A. G., Chen, Y., Nair, A. R., Yang, H., Ren, D., Tang, R. L. Q., Sykes, J., Kovacs, M. S., Dey, D., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.10.034 · Cited by 102
Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
Yang, J., Guo, Q., Feng, X., Liu, Y., & Zhou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841523 · Cited by 105
Moving Forwards by Blocking Back-Flow
Pell, V. R., Chouchani, E. T., Murphy, M. P., Brookes, P. S., & Krieg, T. (2016) · Circulation Research · doi:10.1161/circresaha.115.306569 · Cited by 104
The Emerging Role of Mitochondrial Targeting in Kidney Disease
Eirin, A., Lerman, A., & Lerman, L. O. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_6 · Cited by 99
Guariento, A., Blitzer, D., Doulamis, I. P., Shin, B., Moskowitzova, K., Orfany, A., Ramirez-Barbieri, G., Staffa, S. J., Zurakowski, D., del Nido, P. J., et al. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.06.111 · Cited by 99
Belle, L., Motreff, P., Mangin, L., Rangé, G., Marcaggi, X., Marie, A., Ferrier, N., Dubreuil, O., Zemour, G., Souteyrand, G., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.115.003388 · Cited by 98
Self-citationJavadov, S. A., Jang, S., Parodi‐Rullán, R. M., Khuchua, Z. A., & Kuznetsov, A. V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2502-4 · Cited by 101
Scheffer, D. D. L., Garcia, A. A., Lee, L., Mochly‐Rosen, D., & Ferreira, J. C. B. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0145 · Cited by 96
Stokfisz, K., Ledakowicz-Polak, A., Zagórski, M., & Zielińska, M. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.006 · Cited by 95
Bloemberg, D., & Quadrilatero, J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00261.2018 · Cited by 100
Metadata
- Authors
- Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., Coste, P., Vanzetto, G., Metge, M., Aupetit, J.-F., Jouve, B., Motreff, P., Tron, C., Labeque, J.-N., Steg, P. G., Cottin, Y., Range, G., Clerc, J., Claeys, M. J., Coussement, P., Prunier, F., Moulin, F., Roth, O., Belle, L., Dubois, P., Barragan, P., Gilard, M., Piot, C., Colin, P., De Poli, F., Morice, M.-C., Ider, O., Dubois-Randé, J.-L., Unterseeh, T., Le Breton, H., Béard, T., Blanchard, D., Grollier, G., Malquarti, V., Staat, P., Sudre, A., Elmer, E., Hansson, M. J., Bergerot, C., Boussaha, I., Jossan, C., Derumeaux, G., Mewton, N., & Ovize, M.
- Affiliations
- Centre Hospitalier Universitaire de Nantes (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Lyon 1 Université (FR)
- Centre Hospitalier De Pau (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Saint-Joseph Saint-Luc (FR)
- Centre Hospitalier Intercommunal Aix-Pertuis (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôpital Charles-Nicolle (FR)
- CHU Dijon Bourgogne (FR)
- Antwerp University Hospital (BE)
- AZ Sint-Jan (BE)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Centre Hospitalier de Mulhouse (FR)
- HUmani - CHU Charleroi-Chimay (BE)
- Clinique du Millénaire (FR)
- Hôpital Privé Jacques Cartier (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Lille’s Cardiology Hospital (FR)
- Lund University (SE)
- ORCID
- Morel, Olivier
- Cayla, Guillaume
- Rioufol, Gilles
- Angoulvant, Denis
- Guérin, Patrice
- Delarche, Nicolas
- Coste, Pierre
- Motreff, Pascal
- Tron, Christophe
- Cottin, Yves
- Claeys, Marc J.
- Prunier, Fabrice
- Barragan, Paul
- Gilard, Martine
- Piot, Christophe
- Unterseeh, Thierry
- Sudre, Arnaud
- Hansson, Magnus J.
- Bergerot, Cyrille
- Jossan, Claire
- Mewton, Nathan
- Ovize, Michel
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-09-10
- Volume
- 373
- Issue
- 11
- Pages
- 1021-1031
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2200357463
- Cited by
- 713
- References
- 34
- Citations by year
- 2026: 38 · 2025: 46 · 2024: 48 · 2023: 55 · 2022: 62 · 2021: 57 · 2020: 75 · 2019: 79 · 2018: 70 · 2017: 70 · 2016: 92 · 2015: 20
- FWCI
- 66.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Lunds Universitet
- Assistance publique-Hôpitaux de Paris
- Universitair Ziekenhuis Antwerpen
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- cyclosporine, ST-elevation myocardial infarction, percutaneous coronary intervention, left ventricular remodeling, ischemia-reperfusion injury, myocardial infarct size, heart failure, intravenous cyclosporine, primary percutaneous coronary intervention, drug safety
- MeSH terms
- Peptidyl-Prolyl Isomerase D, Aged, Combined Modality Therapy, Double-Blind Method, Electrocardiography, Enzyme Inhibitors, Female, Heart Failure, Humans, Injections, Intravenous, Male, Middle Aged, Mortality, Myocardial Infarction, Cyclosporine, Ventricular Remodeling, Cyclophilins, Kaplan-Meier Estimate, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
